- Home
- OTRK vs EDSA Comparison
OTRK vs EDSA Comparison
Compare OTRK & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTRK
- EDSA
- Stock Information
- Founded
- OTRK 2003
- EDSA 2015
- Country
- OTRK United States
- EDSA Canada
- Employees
- OTRK N/A
- EDSA N/A
- Industry
- OTRK Misc Health and Biotechnology Services
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- OTRK Health Care
- EDSA Health Care
- Exchange
- OTRK Nasdaq
- EDSA Nasdaq
- Market Cap
- OTRK 7.1M
- EDSA 6.2M
- IPO Year
- OTRK N/A
- EDSA N/A
- Fundamental
- Price
- OTRK $1.41
- EDSA $2.37
- Analyst Decision
- OTRK Strong Buy
- EDSA Strong Buy
- Analyst Count
- OTRK 1
- EDSA 1
- Target Price
- OTRK $45.00
- EDSA $21.00
- AVG Volume (30 Days)
- OTRK 10.4K
- EDSA 32.2K
- Earning Date
- OTRK 05-13-2025
- EDSA 05-09-2025
- Dividend Yield
- OTRK N/A
- EDSA N/A
- EPS Growth
- OTRK N/A
- EDSA N/A
- EPS
- OTRK N/A
- EDSA N/A
- Revenue
- OTRK $11,239,000.00
- EDSA N/A
- Revenue This Year
- OTRK N/A
- EDSA N/A
- Revenue Next Year
- OTRK $48.09
- EDSA N/A
- P/E Ratio
- OTRK N/A
- EDSA N/A
- Revenue Growth
- OTRK N/A
- EDSA N/A
- 52 Week Low
- OTRK $1.27
- EDSA $1.55
- 52 Week High
- OTRK $7.65
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- OTRK 42.78
- EDSA 53.35
- Support Level
- OTRK $1.58
- EDSA $2.31
- Resistance Level
- OTRK $1.56
- EDSA $2.55
- Average True Range (ATR)
- OTRK 0.09
- EDSA 0.11
- MACD
- OTRK -0.01
- EDSA -0.02
- Stochastic Oscillator
- OTRK 0.00
- EDSA 48.28
About OTRK Ontrak Inc.
Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The Company's technology-enabled platform utilizes claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized care program. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.